Psoriatic Arthritis—New Insights, Challenges, Unmet Needs and Controversies

Dear Colleagues,

Psoriatic arthritis, as part of the whole psoriatic disease spectrum, is one of the most challenging immune-mediated inflammatory diseases (IMIDs). This is mainly due to the large heterogeneity of clinical rheumatological expression and its destructive potential, but also to the association of extra-musculoskeletal manifestations and comorbidities that could impact patient perspectives. The complexity of this condition explains the frequent need to utilize multidisciplinary teams, including rheumatologists, dermatologists, internal medicine specialists, cardiologists, psychotherapists, and more. Fortunately, it can be said without exaggeration that recent years have brought amazing therapeutic advances that have significantly changed the management and prognosis of these patients.

This Special Issue focuses on the latest advances in pathogenesis and treatment but also on clinical and management challenges, unmet needs, and controversies. The goal is to significantly improve knowledge about psoriatic disease and, consequently, to contribute to a better patient prognosis.

We kindly invite you to submit your original research, review articles, and spectacular case reports for this Special Issue.

Dr. Daniela Opris-Belinski
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• psoriatic arthritis
• psoriasis
• enthesitis
• dactylitis
• spondyloarthritis
• radiological progression
• biologics
• JAK-inhibitors
• immune-mediated inflammatory diseases
• comorbidities